National Institutes of Health
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing September 7, 2027.
Overview
This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish…